Biomebank

BiomeBank, located in Thebarton, South Australia, is at the forefront of microbiome therapeutics, dedicated to restoring the gut ecosystem that modern life has diminished. Through their innovative technology and a range of products, they aim to transform healthcare by advancing next-generation microbial therapies that emphasize ecological diversity.

Notably, BiomeBank launched BIOMICTRA, the world's first regulated donor-derived therapy for recurrent Clostridioides difficile infections, making significant strides in the field. Their commitment to research and development promises to unlock new health solutions that cater to a variety of medical needs, including immune and metabolic health.

Generated from the website